Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander‐Tetri, Edward Doo, Kris V. Kowdley et al.|The Lancet|2014Cited by 2.2k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver DiseaseArun J. Sanyal, James Tonascia, Mark L. Van Natta et al.|New England Journal of Medicine|2021Cited by 1.1k
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013Adrian Reuben, William M. Lee, Holly Tillman et al.|Annals of Internal Medicine|2016Cited by 383
Clinical and Neurologic Outcomes in Acetaminophen-Induced Acute Liver Failure: A 21-Year Multicenter Cohort StudyAndrew J. MacDonald, Bilal Hameed, Jaime L. Speiser et al.|Clinical Gastroenterology and Hepatology|2020Cited by 39
Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver FailureBabak J. Orandi, Catherine Dillon, Chandler McLeod et al.|JAMA|2023Cited by 27